Merck Other Non-Current Liabilities 2012-2026 | MRK

Merck other non-current liabilities for the quarter ending March 31, 2026 were $7.661B, a 1.6% increase year-over-year.

  • Merck other non-current liabilities for 2024 were $6.465B, a 26.47% decline from 2023.
  • Merck other non-current liabilities for 2023 were $8.792B, a 5.63% increase from 2022.
  • Merck other non-current liabilities for 2022 were $8.323B, a 11.78% decline from 2021.

Merck Other Non-Current Liabilities 2012-2026 | MRK

  • Merck other non-current liabilities for 2024 were $6.465B, a 26.47% decline from 2023.
  • Merck other non-current liabilities for 2023 were $8.792B, a 5.63% increase from 2022.
  • Merck other non-current liabilities for 2022 were $8.323B, a 11.78% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B